Analysis of the therapeutic functions of novel melanocortin receptor agonists in MC3R-and MC4R-deficient C57BL/6J mice

被引:71
作者
Kumar, K. Ganesh [1 ]
Sutton, Gregory M. [1 ]
Dong, Jesse Z. [2 ]
Roubert, Pierre [3 ]
Plas, Pascale [3 ]
Halem, Heather A. [2 ]
Culler, Michael D. [2 ]
Yang, Hyunwon [4 ]
Dixit, Vishwa D. [4 ]
Butler, Andrew A. [1 ,4 ]
机构
[1] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Neuropeptides Lab, Baton Rouge, LA 70808 USA
[2] Biomeasure Inc, IPSEN, Milford, MA 01757 USA
[3] Ipsen Innovat, Les Ulis, France
[4] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Lab Neuroendocrine Immunol, Baton Rouge, LA 70808 USA
关键词
Obesity; Diabetes; Insulin; Melanocortins; Proopiomelanocortin; Melanocyte-stimulating hormones; MELANOCYTE-STIMULATING HORMONE; FOOD-INTAKE; GLUCOSE-HOMEOSTASIS; HEPATIC STEATOSIS; IN-VIVO; OBESITY; MUTATIONS; INFLAMMATION; OXIDATION; PATHWAY;
D O I
10.1016/j.peptides.2009.07.012
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Melanocortin receptor agonists act in the brain to regulate food intake and body weight and, independently of these actions, affect insulin sensitivity. These experiments investigated the function of novel non-selective melanocortin receptor agonists (BIM-22493, BIM-22511) that cross the blood-brain barrier when administered peripherally. Treatment of diet induced obese C57BL/6J (B6) mice with melanocortin agonists administered peripherally improved obesity, hyperinsulinemia (similar to 50%) and fatty liver disease. Specificity of function was determined using B6 melanocortin-3 and melanocortin-4 receptor knockout mice (MC3RKO, MC4RKO). Chow fed MC4RKO but not MC3RKO used for these tests exhibited obesity, hyperinsulinemia and severe hepatosteatosis associated with increased expression of insulin-stimulated genes involved in lipogenesis. Reduced food intake associated with acute BIM-22493 treatment, and weight loss associated with 14 days of treatment with BIM-22511, required functional MC4R but not MC3R. However, while 14 days of treatment with BIM-22511 did not affect body weight and even increased cumulative food intake in MC4RKO, a significant reduction (similar to 50%) in fasting insulin was still observed. Despite lowering insulin, chronic treatment with BIM-22511 did not improve hepatosteatosis in MC4RKO, and did not affect hepatic lipogenic gene expression. Together, these results demonstrate that peripherally administered melanocortin receptor agonists regulate body weight, liver metabolism and glucose homeostasis through independent pathways. MC4R are necessary for melanocortin agonist-induced weight loss and improvements in liver metabolism, but are not required for improvements in hyperinsulinemia. Agonists with activity at MC4R improve glucose homeostasis at least partially by causing weight loss, however other melanocortin receptors may have potential for treating aberrations in glucose homeostasis associated with obesity. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:1892 / 1900
页数:9
相关论文
共 38 条
[1]   Impaired coordination of nutrient intake and substrate oxidation in melanocortin-4 receptor knockout mice [J].
Albarado, DC ;
McClaine, J ;
Stephens, JM ;
Mynatt, RL ;
Ye, JP ;
Bannon, AW ;
Richards, WG ;
Butler, AA .
ENDOCRINOLOGY, 2004, 145 (01) :243-252
[2]   Peripheral effect of α-melanocyte-stimulating hormone on fatty acid oxidation in skeletal muscle [J].
An, Juan Ji ;
Rhee, Yumie ;
Kim, Se Hwa ;
Kim, Dol Mi ;
Han, Dong-He ;
Hwang, Jung Hee ;
Jin, Young-Jun ;
Cha, Bong Soo ;
Baik, Ja-Hyun ;
Lee, Won Tae ;
Lim, Sung-Kil .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (05) :2862-2870
[3]   Divergence of melanocortin pathways in the control of food intake and energy expenditure [J].
Balthasar, N ;
Dalgaard, LT ;
Lee, CE ;
Yu, J ;
Funahashi, H ;
Williams, T ;
Ferreira, M ;
Tang, V ;
McGovern, RA ;
Kenny, CD ;
Christiansen, LM ;
Edelstein, E ;
Choi, B ;
Boss, O ;
Aschkenasi, C ;
Zhang, CY ;
Mountjoy, K ;
Kishi, T ;
Elmquist, JK ;
Lowell, BB .
CELL, 2005, 123 (03) :493-505
[4]   Molecular mediators of hepatic steatosis and liver injury [J].
Browning, JD ;
Horton, JD .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (02) :147-152
[5]   α-melanocyte-stimulating hormone and related tripeptides:: Biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases [J].
Brzoska, Thomas ;
Luger, Thomas A. ;
Maaser, Christian ;
Abels, Christoph ;
Boehm, Markus .
ENDOCRINE REVIEWS, 2008, 29 (05) :581-602
[6]   A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse [J].
Butler, AA ;
Kesterson, RA ;
Khong, K ;
Cullen, MJ ;
Pelleymounter, MA ;
Dekoning, J ;
Baetscher, M ;
Cone, RD .
ENDOCRINOLOGY, 2000, 141 (09) :3518-3521
[7]   The melanocortin system and energy balance [J].
Butler, AA .
PEPTIDES, 2006, 27 (02) :281-290
[8]   The leptin-like effects of 3-d peripheral administration of a melanocortin agonist are more marked in genetically obese zucker (fa/fa) than in lean rats [J].
Cettour-Rose, P ;
Rohner-Jeanrenaud, F .
ENDOCRINOLOGY, 2002, 143 (06) :2277-2283
[9]   Role of the melanocortin-4 receptor in metabolic rate and food intake in mice [J].
Chen, AS ;
Metzger, JM ;
Trumbauer, ME ;
Guan, XM ;
Yu, H ;
Frazier, EG ;
Marsh, DJ ;
Forrest, MJ ;
Gopal-Truter, S ;
Fisher, J ;
Camacho, RE ;
Strack, AM ;
Mellin, TN ;
MacIntyre, DE ;
Chen, HY ;
Van der Ploeg, LHT .
TRANSGENIC RESEARCH, 2000, 9 (02) :145-154
[10]   Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass [J].
Chen, AS ;
Marsh, DJ ;
Trumbauer, ME ;
Frazier, EG ;
Guan, XM ;
Yu, H ;
Rosenblum, CI ;
Vongs, A ;
Feng, Y ;
Cao, LH ;
Metzger, JM ;
Strack, AM ;
Camacho, RE ;
Mellin, TN ;
Nunes, CN ;
Min, W ;
Fisher, J ;
Gopal-Truter, S ;
MacIntyre, DE ;
Chen, HY ;
Van der Ploeg, LHT .
NATURE GENETICS, 2000, 26 (01) :97-102